Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: A large case-control study and meta-analysis

References

• Ortega, L. M., D. R. Schultz, O. Lenz, et al. 2010. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 19: 557–574
   PubMed Web of Science ®Google Scholar
• Zhou, X. J., J. C. Lv, W. R. Cheng, et al. 2010. Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. Clin. Exp. Rheumatol. 28: 397–400
   PubMed Web of Science ®Google Scholar
• Yang, X. W., Y. Tan, F. Yu, and M. H. Zhao. 2012. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein. Hum. Immunol. 73: 156–163
   PubMed Web of Science ®Google Scholar
• Nowling, T. K., and G. S. Gilkeson. 2011. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 13: 250
   PubMed Web of Science ®Google Scholar
• Sjowall, C., A. I. Olin, T. Skogh, et al. 2013. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Autoimmunity 46: 205–214
   PubMed Web of Science ®Google Scholar
• Loetscher, P., M. Uguccioni, L. Bordoli, et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344–345
   PubMed Web of Science ®Google Scholar
• Mack, M., J. Cihak, C. Simonis, et al. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166: 4697–4704
   PubMed Web of Science ®Google Scholar
• Raport, C. J., J. Gosling, V. L. Schweickart, et al. 1996. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 271: 17161–17166
   PubMed Web of Science ®Google Scholar
• Ruffing, N., N. Sullivan, L. Sharmeen, et al. 1998. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell Immunol. 189: 160–168
   PubMed Web of Science ®Google Scholar
• Perez, D. L. G., H. Maier, E. Nieto, et al. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12: 1369–1382
   PubMed Web of Science ®Google Scholar
• Ishikawa, S., T. Sato, M. Abe, et al. 2001. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193: 1393–1402
   PubMedGoogle Scholar
• Moore, K. J., T. Wada, S. D. Barbee, and V. R. Kelley. 1998. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int. 53: 1631–1641
   PubMed Web of Science ®Google Scholar
• Lloyd, C. M., A. W. Minto, M. E. Dorf, et al. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185: 1371–1380
   PubMed Web of Science ®Google Scholar
• Panzer, U., A. Schneider, J. Wilken, et al. 1999. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int. 56: 2107–2115
   PubMed Web of Science ®Google Scholar
• Wada, T., K. Furuichi, C. Segawa-Takaeda, et al. 1999. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int. 56: 995–1003
   PubMed Web of Science ®Google Scholar
• Segerer, S., M. MacK, H. Regele, et al. 1999. Expression of the C–C chemokine receptor 5 in human kidney diseases. Kidney Int. 56: 52–64
   PubMed Web of Science ®Google Scholar
• Furuichi, K., T. Wada, N. Sakai, et al. 2000. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am. J. Nephrol. 20: 291–299
   PubMed Web of Science ®Google Scholar
• Chan, R. W., F. M. Lai, E. K. Li, et al. 2006. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis. Nephrology (Carlton) 11: 219–225
   PubMed Web of Science ®Google Scholar
• Liu, R., W. A. Paxton, S. Choe, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367–377
   PubMed Web of Science ®Google Scholar
• Aguilar, F., A. Nunez-Roldan, B. Torres, et al. 2003. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770–1774
   PubMed Web of Science ®Google Scholar
• Ye, D., S. Yang, X. Li, et al. 2004. Gene mutation of RANTES and CCR5 in systemic lupus erythematosus. Zhonghua Pifuke Zazhi 37: 18–21
   Google Scholar
• Martens, H. A., S. Gross, G. van der Steege, et al. 2010. Lack of association of C-C chemokine receptor 5 Delta32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity. J. Rheumatol. 37: 2226–2231
   PubMed Web of Science ®Google Scholar
• Martens, H. A., C. G. Kallenberg, and M. Bijl. 2009. Role of CCR5 Delta32 bp deletion in RA and SLE. Autoimmunity 42: 260–262
   PubMed Web of Science ®Google Scholar
• Turner, J. E., H. J. Paust, S. B. Bennstein, et al. 2012. Protective role for CCR5 in murine lupus nephritis. Am. J. Physiol. Renal Physiol. 302: F1503–F1515
   Web of Science ®Google Scholar
• Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
   PubMed Web of Science ®Google Scholar
• Weening, J. J., V. D. D'Agati, M. M. Schwartz, et al. 2004. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15: 241–250
   PubMed Web of Science ®Google Scholar
• Weening, J. J., V. D. D'Agati, M. M. Schwartz, et al. 2004. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65: 521–530
   PubMed Web of Science ®Google Scholar
• Chies, J. A., and M. H. Hutz. 2003. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz. J. Med. Biol. Res. 36: 71–75
   PubMed Web of Science ®Google Scholar
• Thakkinstian, A., P. McElduff, C. D'Este, et al. 2005. A method for meta-analysis of molecular association studies. Stat. Med. 24: 1291–1306
   PubMed Web of Science ®Google Scholar
• Egger, M., S. G. Davey, M. Schneider, and C. Minder. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634
   PubMed Web of Science ®Google Scholar
• Begg, C. B., and M. Mazumdar. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088–10101
   PubMed Web of Science ®Google Scholar
• Schauren, J. S., J. A. Marasca, T. D. Veit, et al. 2013. CCR5delta32 in systemic lupus erythematosus: implications for disease susceptibility and outcome in a Brazilian population. Lupus 22: 802–809
   PubMed Web of Science ®Google Scholar
• Harley, J. B., M. E. Alarcon-Riquelme, L. A. Criswell, et al. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204–210
   PubMed Web of Science ®Google Scholar
• Han, J. W., H. F. Zheng, Y. Cui, et al. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41: 1234–1237
   PubMed Web of Science ®Google Scholar
• Yang, W., N. Shen, D. Q. Ye, et al. 2010. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6: e1000841
   PubMed Web of Science ®Google Scholar
• Stephens, J. C., D. E. Reich, D. B. Goldstein, et al. 1998. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet. 62: 1507–1515
   PubMed Web of Science ®Google Scholar
• Bodmer, W., and C. Bonilla. 2008. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40: 695–701
   PubMed Web of Science ®Google Scholar
• Kim-Howard, X., A. K. Maiti, J. M. Anaya, et al. 2010. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann. Rheum. Dis. 69: 1329–1332
   PubMed Web of Science ®Google Scholar
• Yang, W., M. Zhao, N. Hirankarn, et al. 2009. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet. 18: 2063–2070
   PubMed Web of Science ®Google Scholar
• Nath, S. K., S. Han, X. Kim-Howard, et al. 2008. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat. Genet. 40: 152–154
   PubMed Web of Science ®Google Scholar
• Han, S., X. Kim-Howard, H. Deshmukh, et al. 2009. Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum. Mol. Genet. 18: 1171–1180
   PubMed Web of Science ®Google Scholar
• Gomez-Reino, J. J., J. L. Pablos, P. E. Carreira, et al. 1999. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 42: 989–992
   PubMed Web of Science ®Google Scholar
• Buhler, M. M., M. Craig, K. C. Donaghue, et al. 2002. CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort. Autoimmunity 35: 457–461
   PubMed Web of Science ®Google Scholar
• Taylor, K. E., S. A. Chung, R. R. Graham, et al. 2011. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 7: e1001311
   PubMed Web of Science ®Google Scholar
• Sanchez, E., A. Nadig, B. C. Richardson, et al. 2011. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann. Rheum. Dis. 70: 1752–1757
   PubMed Web of Science ®Google Scholar
• Morris, D. L., and T. J. Vyse. 2012. Analysis of systemic lupus erythematosus sub-phenotype data for genetic association. Curr. Opin. Rheumatol. 24: 482–488
   PubMed Web of Science ®Google Scholar